Gary Martin Group Llc

Gary Martin Group creates safe drug names designed to help biopharma companies master the art and science of pharmaceutical naming. Through a unique combination of regulatory expertise, creativity and innovation, we are focused on helping clients keep pace in the ever-changing and regulated pharma-naming world. We help companies tackle all aspects of drug naming from early nonproprietary naming and clinical trial branding to name creation, legal screening, linguistic analysis, HCP and consumer market research, name safety review and regulatory submission activities. The results are agility, creativity and safe names. Headquartered in the San Francisco Bay Area, we serve as drug naming partner to all biopharma, medical device and animal health companies worldwide. For more information, visit